Abstract
The family of p21-activated kinases (PAKs) are oncogenic proteins that regulate critical cellular functions. PAKs play central signaling roles in the integrin/CDC42/Rho, ERK/MAPK, PI3K/AKT, NF-κB, and Wnt/β-catenin pathways, functioning both as kinases and scaffolds to regulate cell motility, mitosis and proliferation, cytoskeletal rearrangement, and other cellular activities. PAKs have been implicated in both the development and progression of a wide range of cancers, including breast cancer, pancreatic melanoma, thyroid cancer, and others. Here we will discuss the current knowledge on the structure and biological functions of both group I and group II PAKs, as well as the roles that PAKs play in oncogenesis and progression, with a focus on thyroid cancer and emerging data regarding BRAF/PAK signaling.
Author supplied keywords
Cite
CITATION STYLE
Bautista, L., Knippler, C. M., & Ringel, M. D. (2021). p21-activated kinases in thyroid cancer. Endocrinology (United States), 161(8). https://doi.org/10.1210/ENDOCR/BQAA105
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.